No Data
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)
Tonix Pharma Advances TNX-4800 Lyme Vaccine Program
TD Cowen Maintains Tonix Pharmaceuticals(TNXP.US) With Buy Rating, Maintains Target Price $22
Analysts' Top Healthcare Picks: Dexcom (DXCM), Tonix Pharma (TNXP)
Express News | Tonix Pharmaceuticals: To Initiate Adaptive Phase 2 Field Study for Prevention of Lyme Disease in U.S. in H1 2027 for Tnx-4800, Pending FDA Agreement
Express News | Tonix Pharmaceuticals: Expect to Begin Phase 2 Study of Tonmya for Treatment of Major Depressive Disorder (Mdd) Mid-Year